Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T van Oosterom

Showing results (141-150 of 196) with videos related to

Pageof 20
Sort By:
Bulletin Du Cancer|November 1, 1995
[In vitro effects of piracetam on the radiosensitivity of hypoxic cells (adaptation of MTT assay to hypoxic conditions)]P Lagarde, E E Gheuens, C M De Pooter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma GroupQ G van Hoesel, J Verweij, G Catimel, et al.
Histochemistry|January 1, 1986
Changes in erythropoiesis due to radiation or chemotherapy as studied by flow cytometric determination of peripheral blood reticulocytesH J Tanke, P H van Vianen, F M Emiliani, et al.
British Journal of Cancer|July 2, 1998
Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative GroupM Bontenbal, M Andersson, J Wildiers, et al.
British Journal of Cancer|February 12, 1998
Phase I study on docetaxel and ifosfamide in patients with advanced solid tumoursL C Pronk, D Schrijvers, J H Schellens, et al.
British Journal of Cancer|January 1, 1997
Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancerC J Punt, E E Voest, E Tueni, et al.
Cancer|January 15, 1994
A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesisB G Sorbe, T Högberg, B Glimelius, et al.
Cancer|October 15, 1984
Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycinG Stoter, C P Vendrik, A Struyvenberg, et al.
Cancer|April 1, 1984
Combination chemotherapy with or without hexamethylmelamine in alkylating-agent resistant ovarian carcinomaJ P Neijt, W W ten Bokkel Huinink, M E van der Burg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 1998
Activated oxazaphosphorines are transported predominantly by erythrocytesM S Highley, D Schrijvers, A T Van Oosterom, et al.
Pageof 20

Showing results (141-150 of 196) with videos related to

Sort By:
Pageof 20
Bulletin Du Cancer|November 1, 1995
[In vitro effects of piracetam on the radiosensitivity of hypoxic cells (adaptation of MTT assay to hypoxic conditions)]P Lagarde, E E Gheuens, C M De Pooter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma GroupQ G van Hoesel, J Verweij, G Catimel, et al.
Histochemistry|January 1, 1986
Changes in erythropoiesis due to radiation or chemotherapy as studied by flow cytometric determination of peripheral blood reticulocytesH J Tanke, P H van Vianen, F M Emiliani, et al.
British Journal of Cancer|July 2, 1998
Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative GroupM Bontenbal, M Andersson, J Wildiers, et al.
British Journal of Cancer|February 12, 1998
Phase I study on docetaxel and ifosfamide in patients with advanced solid tumoursL C Pronk, D Schrijvers, J H Schellens, et al.
British Journal of Cancer|January 1, 1997
Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancerC J Punt, E E Voest, E Tueni, et al.
Cancer|January 15, 1994
A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesisB G Sorbe, T Högberg, B Glimelius, et al.
Cancer|October 15, 1984
Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycinG Stoter, C P Vendrik, A Struyvenberg, et al.
Cancer|April 1, 1984
Combination chemotherapy with or without hexamethylmelamine in alkylating-agent resistant ovarian carcinomaJ P Neijt, W W ten Bokkel Huinink, M E van der Burg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 1998
Activated oxazaphosphorines are transported predominantly by erythrocytesM S Highley, D Schrijvers, A T Van Oosterom, et al.
Pageof 20